Antiarthritic effect of bee venom: Inhibition of inflammation mediator generation by suppression of NF-κB through interaction with the p50 subunit
Hye Ji Park
Chungbuk National University, Chungbuk, South Korea
Search for more papers by this authorSeong Ho Lee
Chungbuk National University, Chungbuk, South Korea
Search for more papers by this authorDong Ju Son
Chungbuk National University, Chungbuk, South Korea
Search for more papers by this authorDo Young Yoon
Korea Research Institute of Bioscience and Biotechnology, Taejon, South Korea
Search for more papers by this authorCorresponding Author
Jin Tae Hong
Chungbuk National University, Chungbuk, South Korea
College of Pharmacy, Chungbuk National University, 48, Gaesin-dong, Heungduk-gu, Cheongju, Chungbuk 361-763, South KoreaSearch for more papers by this authorHye Ji Park
Chungbuk National University, Chungbuk, South Korea
Search for more papers by this authorSeong Ho Lee
Chungbuk National University, Chungbuk, South Korea
Search for more papers by this authorDong Ju Son
Chungbuk National University, Chungbuk, South Korea
Search for more papers by this authorDo Young Yoon
Korea Research Institute of Bioscience and Biotechnology, Taejon, South Korea
Search for more papers by this authorCorresponding Author
Jin Tae Hong
Chungbuk National University, Chungbuk, South Korea
College of Pharmacy, Chungbuk National University, 48, Gaesin-dong, Heungduk-gu, Cheongju, Chungbuk 361-763, South KoreaSearch for more papers by this authorAbstract
Objective
To investigate the molecular mechanisms of the antiarthritic effects of bee venom (BV) and melittin (a major component of BV) in a murine macrophage cell line (Raw 264.7) and in synoviocytes obtained from patients with rheumatoid arthritis.
Methods
We evaluated the antiarthritic effects of BV in a rat model of carrageenan-induced acute edema in the paw and in a rat model of chronic adjuvant-induced arthritis. The inhibitory effects of BV and melittin on inflammatory gene expression were measured by Western blotting, and the generation of prostaglandin E2 (PGE2) and nitric oxide (NO) and the intracellular calcium level were assayed. NF-κB DNA binding and transcriptional activity were determined by gel mobility shift assay or by luciferase assay. Direct binding of BV and melittin to the p50 subunit of NF-κB was determined with a surface plasmon resonance analyzer.
Results
BV (0.8 and 1.6 μg/kg) reduced the effects of carrageenan- and adjuvant-induced arthritis. This reducing effect was consistent with the inhibitory effects of BV (0.5, 1, and 5 μg/ml) and melittin (5 and 10 μg/ml) on lipopolysaccharide (LPS; 1 μg/ml)–induced expression of cyclooxygenase 2, cytosolic phospholipase A2, inducible NO synthase, generation of PGE2 and NO, and the intracellular calcium level. BV and melittin prevented LPS-induced transcriptional and DNA binding activity of NF-κB via the inhibition of IκB release and p50 translocation. BV (affinity [Kd] = 4.6 × 10−6M) and melittin (Kd = 1.2 × 10−8M) bound directly to p50.
Conclusion
Target inactivation of NF-κB by directly binding to the p50 subunit is an important mechanism of the antiarthritic effects of BV.
REFERENCES
- 1 Ribardo DA, Crowe SE, Kuhl KR, Peterson JW, Chopra AK. Prostaglandin levels in stimulated macrophages are controlled by phospholipase A2-activating protein and by activation of phospholipase C and D. J Biol Chem 2001; 276: 5467–75.
- 2 Guastadisegni C, Nicolini A, Balduzzi M, Ajmone-Cat MA, Minghetti L. Modulation of PGE2 and TNFα by nitric oxide in resting and LPS-activated RAW 264.7 cells. Cytokine 2002; 19: 175–80.
- 3 Cho KJ, Han SH, Kim BY, Hwang SG, Park KK, Yang KH, et al. Chlorophyllin suppression of lipopolysaccharide-induced nitric oxide production in RAW 264.7 cells. Toxicol Appl Pharmacol 2000; 166: 120–7.
- 4 Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705–8.
- 5 Longo WE, Panesar N, Mazuski J, Kaminski DL. Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents. Prostaglandins Other Lipid Mediat 1998; 56: 325–9.
- 6 Williams JA, Shacter E. Regulation of macrophage cytokine production by prostaglandin E2: distinct roles of cyclooxygenase-1 and -2. J Biol Chem 1997; 272: 25693–9.
- 7 Chen CC, Chiu KT, Sun YT, Chen WC. Role of the cyclic AMP-protein kinase A pathway in lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of cyclooxygenase-2. J Biol Chem 1999; 274: 31559–64.
- 8 Baek SH, Kwon TK, Lim JH, Lee YJ, Chang HW, Lee SJ, et al. Secretory phospholipase A2-potentiated inducible nitric oxide synthase expression by macrophages requires NF-κB activation. J Immunol 2000; 164: 6359–65.
- 9 Baek SH, Yun SS, Kwon TK, Kim JR, Chang HW, Kwak JY, et al. The effects of two new antagonists of secretory PLA2 on TNF, iNOS, and COX-2 expression in activated macrophages. Shock 1999; 12: 473–8.
- 10 Tintinger GR, Anderson R, Ker JA. Regulation of calcium homeostasis in activated human neutrophils: potential targets for anti-inflammatory therapeutic strategies. S Afr Med J 2002; 92: 990–6.
- 11 Devaux Y, Seguin C, Grosjean S, de Talance N, Camaeti V, Burlet A, et al. Lipopolysaccharide-induced increase of prostaglandin E2 is mediated by inducible nitric oxide synthase activation of the constitutive cyclooxygenase and induction of membrane-associated prostaglandin E synthase. J Immunol 2001; 167: 3962–71.
- 12 Chen BC, Hsieh SL, Lin WW. Involvement of protein kinases in the potentiation of lipopolysaccharide-induced inflammatory mediator formation by thapsigargin in peritoneal macrophages. J Leukoc Biol 2001; 69; 280–8.
- 13 Stephenson DT, Manetta JV, White DL, Chiou XG, Cox L, Gitter B, et al. Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes. Brain Res 1994; 637: 97–105.
- 14 Kramer RM, Sharp JD. Structure, function and regulation of Ca2+-sensitive cytosolic phospholipase A2 (cPLA2) [review]. FEBS Lett 1997; 410: 49–53.
- 15 Cernuda-Morollon E, Pineda-Molina E, Canada FJ, Perez-Sala D. 15-deoxy-Δ12,14-prostaglandin J2 inhibition of NF-κB-DNA binding through covalent modification of the p50 subunit. J Biol Chem 2001; 276: 35530–6.
- 16 Yadav PN, Liu Z, Rafi MM. A diarylheptanoid from lesser galangal (Alpinia officinarum) inhibits proinflammatory mediators via inhibition of mitogen-activated protein kinase, p44/42, and transcription factor nuclear factor-κB. J Pharmacol Exp Ther 2003; 305: 925–31.
- 17 Banerjee T, Valacchi G, Ziboh VA, van der Vliet A. Inhibition of TNFα-induced cyclooxygenase-2 expression by amentoflavone through suppression of NF-κB activation in A549 cells. Mol Cell Biochem 2002; 238: 105–10.
- 18 Price JH, Hillman KS, Toral ME, Newell S. The public's perceptions and misperceptions of arthritis. Arthritis Rheum 1983; 26: 1023–8.
- 19 Jentsch J, Mucke HW. Bee venom peptides. XVIII. Peptide-m and mcd-peptide: isolation and characterization. Int J Pept Protein Res 1977; 9: 78–9.
- 20 Kwon YB, Lee HJ, Han HJ, Mar WC, Kang SK, Yoon OB, et al. The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci 2002; 71: 191–204.
- 21 Kwon YB, Lee JD, Lee HJ, Han HJ, Mar WC, Kang SK, et al. Bee venom injection into an acupuncture point reduces arthritis associated edema and nociceptive responses. Pain 2001; 90: 271–80.
- 22 Sugishita E, Amagaya S, Ogihara Y. Anti-inflammatory testing methods: comparative evaluation of mice and rats. J Pharmacobiodyn 1981; 4: 565–75.
- 23 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24.
- 24 Grisham MB, Johnson GG, Lancaster JR Jr. Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol 1996; 268: 237–46.
- 25 Akiba S, Hatazawa R, Ono K, Kitatani K, Hayama M, Sato T. Secretory phospholipase A2 mediates cooperative prostaglandin generation by growth factor and cytokine independently of preceding cytosolic phospholipase A2 expression in rat gastric epithelial cells. J Biol Chem 2001; 276: 21854–62.
- 26 Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440–50.
- 27 Lee JH, Koo TH, Hwang BY, Lee JJ. Kaurane diterpene, kamebakaurin, inhibits NF-κB by directly targeting the DNA-binding activity of p50 and blocks the expression of antiapoptotic NF-κB target genes. J Biol Chem 2002; 277: 18411–20.
- 28 Billingham ME, Morley J, Hanson JM, Shipolini RA, Vernon CA. An anti-inflammatory peptide from bee venom [letter]. Nature 1973; 245: 163–4.
- 29 Abramson SB, Amin AR, Clancy RM, Attur M. The role of nitric oxide in tissue destruction [review]. Best Pract Res Clin Rheumatol 2001; 15: 831–-45.
- 30 Abramson SB, Attur M, Amin AR, Clancy R. Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis [review]. Curr Rheumatol Rep 2001; 3: 535—41.
- 31 Hotchkiss RS, Bowling WM, Karl IE, Osborne DF, Flye MW. Calcium antagonists inhibit oxidative burst and nitrite formation in lipopolysaccharide-stimulated rat peritoneal macrophages. Shock 1997; 8: 170–8.
- 32 Meador R, Hsia E, Kitumnuaypong T, Schumacher HR. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis [review]. Clin Exp Rheumatol 2002; 20 Suppl 28: S130–4.
- 33 Nakade S, Rhee SK, Hamanaka H, Mikoshiba K. Cyclic AMP-dependent phosphorylation of an immunoaffinity-purified homotetrameric inositol 1,4,5-trisphosphate receptor (type I) increases Ca2+ flux in reconstituted lipid vesicles. J Biol Chem 1994; 269: 6735–42.
- 34 Jeon YJ, Kim YK, Lee M, Park SM, Han SB, Kim HM. Radicicol suppresses expression of inducible nitric-oxide synthase by blocking p38 kinase and nuclear factor-κB/Rel in lipopolysaccharide-stimulated macrophages. J Pharmacol Exp Ther 2000; 294: 548–54.
- 35 Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation [review]. Mutat Res 2001; 480-481: 243–68.
- 36 Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A 1993; 90: 3491–5.
- 37 Phelps CB, Sengchanthalangsy LL, Malek S, Ghosh G. Mechanism of κB DNA binding by Rel/NF-κB dimers. J Biol Chem 2000; 275: 24392–9.
- 38 Pineda-Molina E, Klatt P, Vazquez J, Marina A, Garcia de Lacoba M, Perez-Sala D, et al. Glutathionylation of the p50 subunit of NF-κB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry 2001; 40: 14134–42.
- 39 Garcia-Pineres AJ, Castro V, Mora G, Schmidt TJ, Strunck E, Pahl HL, et al. Cysteine 38 in p65/NF-κB plays a crucial role in DNA binding inhibition by sesquiterpene lactones. J Biol Chem 2001; 276: 39713–20.
- 40 Kim IY, Stadtman TC. Inhibition of NF-κB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment. Proc Natl Acad Sci U S A 1997; 94: 12904–7.
- 41 Haridas V, Arntzen CJ, Gutterman JU. Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), inhibit activation of nuclear factor-κB by inhibiting both its nuclear localization and ability to bind DNA. Proc Natl Acad Sci U S A 2001; 98: 11557–62.
- 42 Toledano MB, Leonard WJ. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci U S A 1991; 88: 4328–32.
- 43 Haddad JJ, Safieh-Garabedian B, Saade NE, Lauterbach R. Inhibition of glutathione-related enzymes augments LPS-mediated cytokine biosynthesis: involvement of an IκB/NF-κB-sensitive pathway in the alveolar epithelium. Int Immunopharmacol 2002; 2: 1567–83.
- 44 Majumdar S, Aggarwal BB. Adenosine suppresses activation of nuclear factor-κB selectively induced by tumor necrosis factor in different cell types. Oncogene 2003; 22: 1206–18.